Challenges To The Indian Drug Industry Subtle, Manifold and More Potent Now, Pharma Lobby Tells Government
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - A spate of adverse moves by developed countries and international agencies in the past year have been most challenging for the Indian drug industry, says the Indian Pharmaceutical Alliance - the lobby of top Indian generic drug makers